The myelofibrosis drug landscape has become more crowded since Syntara decided to focus on the disease in 2020, but the ...
While the myelofibrosis drug landscape has become more crowded since Syntara (then Pharmaxis) decided to focus on that ...
All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
The partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.
Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with Boehringer Ingelheim to accelerate ...
Salipro Biotech has signed a research and license agreement with Boehringer Ingelheim to accelerate the development of ...